We selected this strategy mainly because PharmAla is really a “regulatory-1st” Corporation: we know that there is no pathway to drug approval with no belief from regulators.The active pharmaceutical ingredients market place is accelerating at a robust pace because of multiple factors, such as increasing prevalence of health conditions, improvem